Skip to main content

Détection des cas de COVID-19 en médecine de ville : GERS Data recense un ralentissement de la baisse de nouveaux cas

Boulogne-Billancourt, le 27 avril 2020 – Depuis le début du confinement, GERS Data, société du Groupe Cegedim, fournit aux autorités de santé des statistiques indispensables à la consommation de soins en France, le respect du bon usage, l’état des stocks à l’hôpital comme en ville pour tous les produits de santé, notamment ceux indispensables aux soins intensifs. Le suivi de l’activité des médecins et des pharmaciens permet au plus haut niveau de l’Etat d’avoir une vision sur la continuité de l’offre de soins, en présentiel ou via téléconsultation pour tous les concitoyens.À travers l’observatoire THIN (The Health Improvement Network), composé de 2 000 médecins généralistes et 1 000 spécialistes en France, GERS Data suit quotidiennement l’évolution du nombre de cas COVID-19.L’évolution des diagnostics COVID-19 ci-dessous permet ainsi d’aider à comprendre ce que pourrait être la situation au 11 mai, date de sortie progressive du confinement.Si le nombre de nouveaux cas de COVID-19 recensé par les médecins généralistes en France continue de diminuer, cette baisse semble pourtant subir un ralentissement comme l’indique les chiffres des tableaux ci-dessous. – Graphiques disponibles auprès du service de presse –  Pièce jointeGERSData_COVID19_Data27042020

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.